Microsoft and Apple Step Back from OpenAI's Board Amid Antitrust Concerns

Full Article

Microsoft and Apple have stepped down from OpenAI's board due to increasing antitrust scrutiny from regulatory bodies in the US, UK, and EU. This decision reflects a broader trend of tech companies reassessing their governance structures in light of potential anti-competitive practices. The move aims to alleviate regulatory concerns while maintaining their significant investments in AI.

Microsoft's exit as a non-voting observer follows its substantial $13 billion investment in OpenAI, raising questions about fair competition. Meanwhile, Apple has also chosen to avoid potential regulatory issues despite its collaboration with OpenAI to enhance its AI capabilities. This shift indicates a cautious approach by major tech firms as they navigate the evolving landscape of AI regulation.

• Microsoft and Apple exit OpenAI's board amid regulatory scrutiny.

• Increased antitrust concerns influence major tech companies' governance decisions.

Key AI Terms Mentioned in this Article

Antitrust

The article discusses how antitrust scrutiny is affecting the governance of major tech firms involved in AI.

Non-voting observer

Microsoft's role as a non-voting observer on OpenAI's board raised concerns about its influence and access to confidential information.

Exclusivity clauses

The European Commission's inquiry into Microsoft's exclusivity clauses with OpenAI highlights potential anti-competitive implications.

Companies Mentioned in this Article

Microsoft

Its significant investment in OpenAI and subsequent withdrawal from the board reflect its strategic positioning in the AI landscape.

Apple

Its decision to avoid joining OpenAI's board underscores its cautious approach to regulatory challenges in AI development.

OpenAI

The company's governance changes in response to regulatory scrutiny are pivotal for its future collaborations.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics